The fact that it is possible to detect changes in the p27 protein levels in lymphocytes from AD patients, which could mirror changes thought to occur in the brain prior to neurodegeneration, could offer new venues for diagnostic tools. Here, CDKN1B is linked to Alzheimer disease.